Agree Vinn given revenue compared with similar sized market caps we are well below where we should be. 7-8c would be a fairer price!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025